At A Glance
1
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia.
2
No significant events in the past 90 days.
—
Market Cap
—
Revenue
—
Net Income
Fundamentals
How The Business Makes Money
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.
Industry Biotechnology
Activity
What Changed Recently
No significant events in the past 90 days.
Company Profile
CIKUNKNOWN_BITRF
ISINAU000000BIT4
Phone61 2 9300 3344
Address66 Hunter Street, Sydney, NSW, 2000, AU
SEC EDGAR